-transparent.png){kind=logo}
Fifteen patients with primary Raynaud's phenomenon received captopril 25 mg or placebo, three times daily for 6 weeks, in a randomized double-blind cross-over study. Compared with placebo, captopril produced a significant improvement in cutaneous blood flow but did not alter the frequency or severity of attacks of Raynaud's phenomenon.
Related Publications
M H Rustin, and
N E Almond, and
J A Beacham, and
R J Brooks, and
D P Jones, and
E D Cooke, and
P M Dowd
March 1986,
Angiology,
M H Rustin, and
N E Almond, and
J A Beacham, and
R J Brooks, and
D P Jones, and
E D Cooke, and
P M Dowd
March 1973,
Clinical science,
M H Rustin, and
N E Almond, and
J A Beacham, and
R J Brooks, and
D P Jones, and
E D Cooke, and
P M Dowd
January 1995,
The Journal of rheumatology,
M H Rustin, and
N E Almond, and
J A Beacham, and
R J Brooks, and
D P Jones, and
E D Cooke, and
P M Dowd
December 1988,
British journal of rheumatology,
M H Rustin, and
N E Almond, and
J A Beacham, and
R J Brooks, and
D P Jones, and
E D Cooke, and
P M Dowd
December 1988,
The British journal of dermatology,
M H Rustin, and
N E Almond, and
J A Beacham, and
R J Brooks, and
D P Jones, and
E D Cooke, and
P M Dowd
April 1991,
Clinical science (London, England : 1979),
M H Rustin, and
N E Almond, and
J A Beacham, and
R J Brooks, and
D P Jones, and
E D Cooke, and
P M Dowd
September 1991,
Clinical science (London, England : 1979),
M H Rustin, and
N E Almond, and
J A Beacham, and
R J Brooks, and
D P Jones, and
E D Cooke, and
P M Dowd
January 1987,
Drugs under experimental and clinical research,
M H Rustin, and
N E Almond, and
J A Beacham, and
R J Brooks, and
D P Jones, and
E D Cooke, and
P M Dowd
January 2022,
International journal of clinical practice,
M H Rustin, and
N E Almond, and
J A Beacham, and
R J Brooks, and
D P Jones, and
E D Cooke, and
P M Dowd
May 1974,
Angiology,
